Pricing

Arbutus Biopharma

2 followers

‌

Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).

Industries

Headquarters

Warminster, United States

Employees

Links

Org chart

Michael McElhaugh

CEO

Collapse

David C. Hastings

Chief Financial Officer

Elizabeth Howard

EVP, General Counsel & Chief Compliance Officer

Michael J. Sofia Phd

Chief Scientific Officer

Ganapati Reddy Pamulapati

Senior Vice President, Pharmaceutical Development And Manufacturing

Executive Director Of Information Technology & Information Security

Chief Financial Officer

Tilly Varughese

Medical Director

Sr. Director, Clinical Operations

Senior Director Clinical Operations

Associate Director Clinical Operations

Board & advisors

Chairman

Independent Director

Richard C. Henriques

Independent Director

Keith Manchester

Independent Director

Teams

Scientific and Research Team

11 people · 0 jobs

Clinical Operations Team

7 people · 0 jobs

Finance and Accounting

3 people · 0 jobs

Leadership Team

3 people · 0 jobs

Offices

HQ
17 positions, 0 job posts
LG
+13

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

158 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies